Recent research data published in the September issue of Clinical Gastroenterology and Hepatology confirms that an annual or biennial fecal immunological test (FIT) beginning at age 50 years in combination with a single colonoscopy at age 66 years is as effective as current colorectal cancer (CRC) screening guidelines. Moreover, the hybrid screening strategy requires fewer resources than the current CRC screening protocol. The findings are consistent with a recent US Preventive Services Task Force analysis.
The authors compared the hybrid screening strategy with single-modality screening using annual FIT, sigmoidoscopy every 5 years, and colonoscopy every 10 years. They also… Continue reading →